CTSO
Cytosorbents Corp
$0.64+0.03 (4.92%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Cytosorbents Corp (CTSO) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 13 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | 2025-11-18 | Chan Phillip P. | CEO | Award | 100,000 | $0.64 | $64,000 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Chan Phillip P. | CEO | Award | 105,600 | $0.00 | $0 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Capponi Vincent | COO | Award | 89,100 | $0.00 | $0 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Capponi Vincent | COO | Award | 111,100 | $0.00 | $0 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Mariani Peter J | CFO | Award | 71,500 | $0.00 | $0 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Kim Jiny | Director | Award | 22,000 | $0.00 | $0 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Deliargyris Efthymios | CMO | Award | 70,000 | $0.00 | $0 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Deliargyris Efthymios | CMO | Award | 95,000 | $0.00 | $0 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Jones Edward Raymond | Director | Award | 22,000 | $0.00 | $0 | N/A | N/A |
| 2025-08-08 | 2025-08-08 | Sobel Alan D. | Director | Award | 22,000 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.